[5型磷酸二酯酶抑制剂治疗勃起功能障碍：过去、现在与未来]
[Phosphodiesterase type 5 inhibitors in the treatment of erectile dysfunction: past, present and future].
作者信息
Gamidov S I, Ovchinnikov R I, Popova A Yu, Izhbaev S Kh
机构信息
Department of Andrology and Urology, V.I. Kulakov Research Center for Obstetrics, Gynecology and Perinatology of Minzdrav of Russia, Moscow, Russia.
出版信息
Urologiia. 2017 Apr(1):103-107. doi: 10.18565/urol.2017.1.103-107.
PMID:28394532
Abstract
This review article describes the differences in efficacy and side effects between available phosphodiesterase type 5 (PDE-5) inhibitors used for treating erectile dysfunction. The most studied PDE-5 inhibitor is sildenafil.
摘要
这篇综述文章描述了用于治疗勃起功能障碍的现有5型磷酸二酯酶（PDE - 5）抑制剂在疗效和副作用方面的差异。研究最多的PDE - 5抑制剂是西地那非。
Zotero 插件